Clinicopathologic Characteristics of Renal Cell Carcinoma in Prof. dr. I.G.N.G. Ngoerah General Hospital 2018 – 2022
DOI:
https://doi.org/10.33448/rsd-v12i13.44402Keywords:
Renal cell carcinoma; Epidemiology; Characteristic.Abstract
RCC is a tumor that manifests in proximal tubule epithelial cells and accounts for 3% of total adult neoplastic cases. In Indonesia, RCC cases are still deemed low, but show a tendency to increase annually. This study’s objective is to provide a description on the clinicopathologic features of RCC patients in Prof. dr. I.G.N.G. Ngoerah General Hospital in the province of Bali from 2018 to 2022. This is a cross-sectional study which implemented total sampling in collecting secondary data from the laboratory of anatomical pathology in Prof. dr. I.G.N.G. Ngoerah General Hospital. There were 38 cases of RCC from a total of 108 kidney cases which underwent histopathologic examinations. Descriptive analysis showed that the majority of RCC cases were found in the age range of 51 – 60 years old (36.8%), males (76,3%), left tumor laterality (57,9%), operative procedures for specimen collection (94,7%), ccRCC subtype (63,2%), tumor size of >10 cm (50,0%), grade III – IV (57,9%), and pT3a stage (47,4%). The combination of these clinicopathologic findings suggested that the RCC patients in Bali were shown to be associated with worse prognosis and should consider further analytical studies.
References
Anand, S., Barsouk, A., & Chaitanya, K. (2020). Epidemiology of Renal Cell Carcinoma. World Journal of Oncology, 11(3), 79–87. https://doi.org/10.14740/wjon1279
Andreotti, G., Freeman, L. E. B., Shearer, J. J., Lerro, C. C., Koutros, S., Parks, C. G., Blair, A., Lynch, C. F., Lubin, J. H., Sandler, D. P., & Hofmann, J. N. (2020). Occupational Pesticide Use and Risk of Renal Cell Carcinoma in the Agricultural Health Study. Environmental Health Perspectives, 128(6), 1–10. https://doi.org/10.1289/EHP6334
Brannon, A. R., Haake, S. M., Hacker, K. E., Pruthi, R. S., Wallen, E. M., Nielsen, M. E., & Rathmell, W. K. (2012). Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. European Urology, 61(2), 258–268. https://doi.org/10.1016/j.eururo.2011.10.007.Meta-analysis
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global Cancer Statistics 2018 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Capitanio, U., Coleman, J., Gore, J. L., Sun, M., Wood, C., Russo, P., & Novara, G. (2019). Epidemiology of Renal Cell Carcinoma. European Urology, 75(1), 74–84. https://doi.org/10.1016/j.eururo.2018.08.036
Carrero, J. J., Hecking, M., Chesnaye, N. C., & Jager, K. J. (2018). Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nature Reviews Nephrology, 14(3), 151–164. https://doi.org/10.1038/nrneph.2017.181
Chen, Y., Sun, Y., Rao, Q., Xu, H., Li, L., & Chang, C. (2015). Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status. Oncotarget, 6(31), 31203–31215. https://doi.org/10.18632/oncotarget.4522
Doumas, M., Papademetriou, V., Faselis, C., & Kokkinos, P. (2013). Gender Differences in Hypertension : Myths and Reality. Current Hypertension Reports, 15(4), 321–330. https://doi.org/10.1007/s11906-013-0359-y
Duha, D. A., Harahap, E. U., Santoso, R. B., & Bramono, I. A. (2022). Kidney Cancer Profile in National Cancer Center ( NCC ) - Dharmais Cancer Hospital. Indonesian Journal of Cancer, 16(4), 226–230. https://doi.org/10.33371/ijoc.v16i4.904
Dy, G. W., Gore, J. L., Forouzanfar, M. H., Naghavi, M., Fitzmaurice, C., & Catto, J. (2017). Global Burden of Urologic Cancers , 1990 – 2013. European Urology, 71(3), 437–446. https://doi.org/10.1016/j.eururo.2016.10.008
Gelfond, J., Al-bayati, O., Kabra, A., Iffrig, K., Kaushik, D., & Liss, M. A. (2018). Modifiable risk factors to reduce renal cell carcinoma incidence : Insight from the PLCO trial. Urologic Oncology: Seminars and Original Investigations, 36(7), 340. https://doi.org/10.1016/j.urolonc.2018.04.011
Guo, S., Yao, K., He, X., Wu, S., Ye, Y., Chen, J., & Wu, C.-L. (2019). Prognostic significance of laterality in renal cell carcinoma : A population ‐ based study from the surveillance , epidemiology , and end results (SEER) database. Cancer Medicine, 8(12), 5629–5637. https://doi.org/10.1002/cam4.2484
Halverson, S. J., Kunju, L. P., Bhalla, R., Gadzinski, A. J., Alderman, M., Miller, D. C., Montgomery, J. S., Weizer, A. Z., Wu, A., Hafez, K. S., & Wolf Jr, J. S. (2013). Accuracy of Determining Small Renal Mass Management with Risk Stratified Biopsies : Confirmation by Final Pathology. The Journal of Urology, 189(2), 441–446. https://doi.org/10.1016/j.juro.2012.09.032
Hew, M. N., Zonneveld, R., Kümmerlin, P. E. D., Opondo, D., Rosette, J. J. M. C. H. De, & Laguna, M. P. (2012). Age and gender related differences in renal cell carcinoma in a European cohort. The Journal of Urology, 188(1), 33–38. https://doi.org/10.1016/j.juro.2012.02.2573
Howlander, N., Noone, A., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D., Chen, H., Feuer, E., & Cronin, K. (2020). SEER Cancer Statistics Review (CSR) 1975-2016. National Cancer Institute; National Cancer Institute. https://seer.cancer.gov/csr/1975_2016/
Keegan, K. A., Schupp, C. W., Chamie, K., Hellenthal, N. J., Evans, C. P., & Koppie, T. M. (2012). Histopathology in Surgically Treated Renal Cell Carcinoma: Survival Differences by Subtype and Stage. The Journal of Urology, 188(2), 391–397. https://doi.org/10.1016/j.juro.2012.04.006.Histopathology
Klatte, T., Rossi, S. H., & Stewart, G. D. (2018). Prognostic factors and prognostic models for renal cell carcinoma : a literature review. World Journal of Urology, 36(12), 1943–1952. https://doi.org/10.1007/s00345-018-2309-4
Kurban, L. A. S., Vosough, A., Jacob, P., Prasad, D., Lam, T., Scott, N., Somani, B. K., & Somani, B. K. (2017). Pathological nature of renal tumors ‑ does size matter ? Urology Annals, 9(4), 330–334. https://doi.org/10.4103/UA.UA_17_17
Laskar, R. S., Muller, D. C., Li, P., Machiela, M. J., Ye, Y., Gaborieau, V., Foll, M., Hofmann, J. N., Colli, L., Sampson, J. N., Wang, Z., Anne, D. B., Behnoush, B., Durand, A. G., Le, F., Robinot, N., Blanche, H., Prokhortchouk, E., Skryabin, K. G., & Scelo, G. (2019). Sex specific associations in genome wide association analysis of renal cell carcinoma. European Journal of Human Genetics, 27(10), 1589–1598. https://doi.org/10.1038/s41431-019-0455-9
Macleod, L. C., Hotaling, J. M., Wright, J. L., Davenport, M. T., Gore, J. L., Harper, J., & White, E. (2013). Risk Factors for Renal Cell Carcinoma in the Vitamin and Lifefstyle (VITAL) Study. The Journal of Urology, 190(5), 1657–1661. https://doi.org/10.1016/j.juro.2013.04.130.Risk
Mancini, M., Righetto, M., & Baggio, G. (2020). Gender-Related Approach to Kidney Cancer Management : Moving Forward. International Journal of Molecular Sciences, 21(9), 3378. https://doi.org/10.3390/ijms21093378
Melisa, J., Monoarfa, A., & Tjandra, F. (2016). Profil penderita karsinoma sel ginjal (renal cell carcinoma) di RSUP Prof. Dr. R. D. Kandou Manado periode 2013-2015. E-CliniC, 4(2). https://doi.org/10.35790/ecl.v4i2.14501
Merchán-Hamann, E., & Tauil, P. L. (2021). Proposal for classifying the different types of descriptive epidemiological studies. Epidemiology and Health Services, 30(1). https://doi.org/10.1590/S1679-49742021000100026
Moch, H., Amin, M. B., Argani, P., Cheville, J., Delahunt, B., Martignoni, G., Medeiros, L. J., Srigley, J. R., Tan, P. H., & Tickoo, S. K. (2016). Introduction. In H. Moch, P. A. Humphrey, T. M. Ulbright, & V. E. Reuter (Eds.), WHO Classification of Tumours of the Urinary System and Male Genital Organs (4th Ed., pp. 14–17). World Health Organization.
Mutuiri, A., & Gakinya, S. (2022). Clinicopathologic features of renal cell carcinomas seen at the Aga Khan University Hospital in Kenya. Frontiers in Medicine, 9, 981305. https://doi.org/10.3389/fmed.2022.981305
Noh, S. J., Kang, M. J., Kim, K. M., Bae, J. S., Park, H. S., Moon, W. S., Chung, M. J., Lee, H., Lee, D. G., & Jang, K. Y. (2013). Acetylation status of P53 and the expression of DBC1 , SIRT1 , and androgen receptor are associated with survival in clear cell renal cell carcinoma patients. Pathology, 45(6), 574–580. https://doi.org/10.1097/PAT.0b013e3283652c7a
Pallagani, L., Choudhary, G. R., Himanshu, P., Madduri, V. K. S., Gupta, P., Shrivastava, N., Baid, G., Meenakshi, R., Aasma, N., & Sanjeev, M. (2021). Epidemiology and Clinicopathological Profile of Renal Cell Carcinoma : A Review from Tertiary Care Referral Centre. Journal of Kidney Cancer and VHL, 8(1), 1–6. https://doi.org/10.15586/jkcvhl.2021.154
Peired, A. J., Antonelli, G., Angelotti, M. L., Allinovi, M., Guzzi, F., Sisti, A., Semeraro, R., Conte, C., Mazzinghi, B., Nardi, S., Melica, M. E., Chiara, L. De, Lazzeri, E., Lasagni, L., Lottini, T., Landini, S., Giglio, S., Mari, A., Maida, F. Di, … Romagnani, P. (2020). Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells. Science Translational Medicine, 12(536), 1–17. https://doi.org/10.1126/scitranslmed.aaw6003
Peired, A. J., Campi, R., Angelotti, M. L., Antonelli, G., Conte, C., Lazzeri, E., Becherucci, F., Calistri, L., Serni, S., & Romagnani, P. (2021). Sex and Gender Differences in Kidney Cancer : Clinical and Experimental Evidence. Cancers, 13(18), 4588. https://doi.org/10.3390/cancers13184588
Pesch, B., Haerting, J., Ranft, U., Klimpel, A., Oelschlägel, B., & Schill, W. (2000). Occupational risk factors for renal cell carcinoma : agent-specific results from a case-control study in Germany. International Journal of Epidemiology, 29(6), 1014–1024. https://doi.org/10.1093/ije/29.6.1014
Rabjerg, M., Gerke, O., Engvad, B., & Marcussen, N. (2021). Comparing World Health Organization / International Society of Urological Pathology Grading and Fuhrman Grading with the Prognostic Value of Nuclear Area in Patients with Renal Cell Carcinoma. Uro, 1(1), 2–13. https://doi.org/10.3390/uro1010002
Seno, D. W. H., Mochtar, C. A., & Umbas, R. (2011). Terapi Sistemik Terkini pada Karsinoma. Indonesian Journal of Cancer, 5(3). https://doi.org/10.33371/ijoc.v5i3.151
Setiawan, V. W., Kolonel, L. N., & Henderson, B. E. (2009). Menstrual and Reproductive Factors and Risk of Renal Cell Cancer in the Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention, 18(1), 337–340. https://doi.org/10.1158/1055-9965.EPI-08-0790.Menstrual
Shrestha, D., Liu, S., Hammond, S. K., Lavalley, M. P., Weiner, D. E., Eisen, E. A., & Applebaum, K. M. (2016). Risk of renal cell carcinoma following exposure to metalworking fluids among autoworkers. Occupational and Environmental Medicine, 73(10), 656–662. https://doi.org/10.1136/oemed-2016-103769.Risk
Strauss, A., Uhlig, J., Lotz, J., Trojan, L., & Uhlig, A. (2019). Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study. Medicine, 17, e15346. https://doi.org/10.1097/MD.0000000000015346
Taneja, K., Cheng, L., Al-Obaidy, K., Kao, C.-S., Barletta, J., Howitt, B. E., Wasco, M. J., Palanisamy, N., Gupta, N. S., Rogers, C. G., Carskadon, S., Chen, Y.-B., Antic, T., Tretiakova, M., & Williamson, S. R. (2019). Clear Cell Renal Cell Carcinoma With a Poorly-Differentiated Component: A Novel Variant Causing Potential Diagnostic Difficulty. Mod Pathol, 32, 147–148.
Vargas, H. A., Chaim, J., Lefkowitz, R. A., Lakhman, Y., Zheng, J., Moskowitz, C. S., Sohn, M. J., Schwartz, L. H., Russo, P., & Akin, O. (2012). Renal cortical tumors: Use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology, 264(3), 779–788. https://doi.org/10.1148/radiol.12110746
Williamson, S. R. (2019). The expanding role of renal mass biopsy. Diagnostic Histopathology, 25(10), 379–389. https://doi.org/10.1016/j.mpdhp.2019.07.003
Xie, Y., Xu, P., Wang, M., Zheng, Y., Tian, T., Yang, S., Deng, Y., Wu, Y., Zhai, Z., Hao, Q., Song, D., Zhang, D., & Dai, Z. (2020). Antihypertensive medications are associated with the risk of kidney and bladder cancer : a systematic review and meta-analysis. Aging, 12(2), 1545–1562. https://doi.org/10.18632/aging.102699
Xu, X., & Zhu, D. (2021). Prognostic significance of subclassifying stage pT3a renal tumors with fat invasion : a retrospective study of 99 patients. Journal of International Medical Research, 49(8). https://doi.org/10.1177/03000605211033178
Yu, C., Ho, J., Huang, Y., Cha, T., Sun, G., Yu, D., Chang, F., Chen, S., & Hsu, R. (2013). Estrogen Inhibits Renal Cell Carcinoma Cell Progression through Estrogen Receptor-β Activation. PLoS ONE, 8(2), e56667. https://doi.org/10.1371/journal.pone.0056667
Zhi, Y., Li, X., Qi, F., Hu, X., & Xu, W. (2020). Association of Tumor Size with Risk of Lymph Node Metastasis in Clear Cell Renal Cell Carcinoma : A Population-Based Study. Journal of Oncology, 20, 8887782. https://doi.org/10.1155/2020/8887782
Zhu, D., Cao, J., Zhi, C., Guo, T., Li, Y., Lang, Z., & Li, G. (2020). Prognostic significance of the sub-classification of stage pT3a renal tumors by perinephric and sinus fat invasion. Oncology Letters, 19, 1721–1726. https://doi.org/10.3892/ol.2020.11281
Zhu, G., Liang, L., Li, L., Dang, Q., Song, W., Yeh, S., He, D., & Chang, C. (2014). The Expression and Evaluation of Androgen Receptor in Human Renal Cell Carcinoma. Urology, 83(2), 19–24. https://doi.org/10.1016/j.urology.2013.10.022
Zucchetto, A., Talamini, R., Maso, L. D., Negri, E., Polesel, J., Ramazzotti, V., Montella, M., Canzonieri, V., Serraino, D., Vecchia, C. La, & Franceschi, S. (2008). Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer. International Journal of Cancer, 123(9), 2213–2216. https://doi.org/10.1002/ijc.23750
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Darren Junior; Ni Wayan Winarti; Ni Putu Sriwidyani; I Gusti Ayu Sri Mahendra Dewi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
